Oxaliplatin in Treating Patients With Liver Cancer

NCT00052364 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

NIH

Sponsor class

Conditions

Adult Primary Hepatocellular Carcinoma
Advanced Adult Primary Liver Cancer
Localized Unresectable Adult Primary Liver Cancer
Recurrent Adult Primary Liver Cancer

Interventions

DRUG: oxaliplatin
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)